C12Y 204/01274
Glucosylceramide beta-1,4-galactosyltransferase
Official title: Glucosylceramide beta-1,4-galactosyltransferase (2.4.1.274)
C12Y204/01274 (Glucosylceramide beta-1,4-galactosyltransferase) appears on 1 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 5
- Assignees
- 5
- Inventors
- 18
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods relating to age-related, neurological, and vascular disease conditions20 Aug 2026US 2026/0241037 A1The Board of Trustees of the Leland Stanford Junior University
- Antisense oligonucleotides for the treatment of cardiovascular disease23 Jul 2026US 2026/0207775 A1ProQR Therapeutics II B.V.
- Production of Milk Oligosaccharides in Plants5 Dec 2024US 2024/0401069 A1The Regents of the University of California
- A transgenic invertebrate model for alzheimer's disease and use thereof29 Jul 2021US 2021/0227814 A1National Center for Geriatrics and Gerontology
- Preventive/Therapeutic Drug for Arteriosclerosis25 Oct 2007US 2007/0248591 A1Takeda Pharmaceutical Company Limited
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.